Polyclonal intravenous immunoglobulin: An important additional strategy in sepsis?

This publication has 59 references indexed in Scilit:

• Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2–dependent prostaglandin E2 in human dendritic cells
  Blood, 2013
• Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients
  International Immunopharmacology, 2011
• Dose-Dependent Effect of Anti-CTLA-4 on Survival in Sepsis
  Shock, 2011
• Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin
  Journal of Allergy and Clinical Immunology, 2011
• PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
  Proceedings of the National Academy of Sciences, 2009
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
  Intensive Care Medicine, 2007
• MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis
  Journal of Experimental Medicine, 2007
• IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: A randomized, controlled, multiple-center trial*
  Critical Care Medicine, 2006
• Evidence for Antibody-Catalyzed Ozone Formation in Bacterial Killing and Inflammation
  Science, 2002
• Relative Neutralizing Activity in Polyspecific IgM, IgA, and IgG Preparations against Group A Streptococcal Superantigens
  Clinical Infectious Diseases, 2000